Exact Therapeutics (Norway) Technical Analysis

EXTX Stock  NOK 3.80  0.02  0.53%   
As of the 12th of December 2024, Exact Therapeutics shows the Standard Deviation of 5.16, mean deviation of 2.02, and Coefficient Of Variation of (1,254). Exact Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Exact Therapeutics information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Exact Therapeutics is priced favorably, providing market reflects its regular price of 3.8 per share.

Exact Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Exact, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Exact
  
Exact Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Exact Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Exact Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Exact Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Exact Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Exact Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Exact Therapeutics Trend Analysis

Use this graph to draw trend lines for Exact Therapeutics AS. You can use it to identify possible trend reversals for Exact Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Exact Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Exact Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Exact Therapeutics AS applied against its price change over selected period. The best fit line has a slop of   0.02  , which may suggest that Exact Therapeutics AS market price will keep on failing further. It has 122 observation points and a regression sum of squares at 8.79, which is the sum of squared deviations for the predicted Exact Therapeutics price change compared to its average price change.

About Exact Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Exact Therapeutics AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Exact Therapeutics AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Exact Therapeutics price pattern first instead of the macroeconomic environment surrounding Exact Therapeutics. By analyzing Exact Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Exact Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Exact Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Exact Therapeutics December 12, 2024 Technical Indicators

Most technical analysis of Exact help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Exact from various momentum indicators to cycle indicators. When you analyze Exact charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Exact Therapeutics December 12, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Exact stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Exact Stock

Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.